GARS1 mRNA overexpression, found at the tissue level, has recently been linked to poor prognosis for hepatocellular carcinoma (Wang et al., 2022) and was selected as a urinary protein marker for the diagnosis of urothelial carcinoma (Chen et al., 2021). Here, GARS1 is linked to urothelial carcinoma.